[The Lancet Global Health] Inclusion of Young Adolescents in Policy Development for New TB Vaccines

15 June 2026

Health Policy article in The Lancet Global Health

A Health Policy article, published in The Lancet Global Health, argued for the inclusion of young adolescents (aged 9–14) in new TB vaccine policy despite challenges like low TB rates in that age group. The authors proposed a novel trial design based on household exposure to rapidly deliver efficacy data and ensure younger adolescents are not excluded from vaccine benefits.

Read the full article here.

Source: The Lancet Global Health